Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Fresenius Medical Care ( (FMS) ) just unveiled an update.
On June 4, 2025, Fresenius Medical Care announced the broader U.S. commercialization of its 5008X CAREsystem, following FDA 510(k) clearance for an updated version with additional features. This milestone marks the second phase of introducing high-volume hemodiafiltration therapy across the U.S., with the first wave of Fresenius Kidney Care clinics set to offer this advanced dialysis therapy. The initiative is part of the company’s growth strategy and aims to set a new standard in kidney care in the U.S., leveraging the positive outcomes of the CONVINCE study, which showed a significant reduction in mortality rates for patients using high-volume hemodiafiltration.
The most recent analyst rating on (FMS) stock is a Sell with a $17.50 price target. To see the full list of analyst forecasts on Fresenius Medical Care stock, see the FMS Stock Forecast page.
Spark’s Take on FMS Stock
According to Spark, TipRanks’ AI Analyst, FMS is a Outperform.
Fresenius Medical Care demonstrates solid financial performance with consistent revenue and strong cash flow. Positive momentum is evident in technical indicators, although valuation metrics suggest potential overvaluation. The company’s strategic initiatives and earnings call guidance support a positive outlook for the year.
To see Spark’s full report on FMS stock, click here.
More about Fresenius Medical Care
Fresenius Medical Care is the world’s leading provider of products and services for individuals with renal diseases, serving approximately 299,000 patients globally through its network of 3,674 dialysis clinics. The company is also a leading provider of dialysis products, including dialysis machines and dialyzers, and is listed on both the Frankfurt Stock Exchange and the New York Stock Exchange.
Average Trading Volume: 455,594
Technical Sentiment Signal: Buy
Current Market Cap: $16.76B
Learn more about FMS stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue